| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912251A1 A dispensing device and method for forming material |
| 05/06/1999 | EP0912184A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 05/06/1999 | EP0912157A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 05/06/1999 | EP0912085A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/06/1999 | EP0721457B1 2',5'-OLIGOADENYLATE-2',3'-CYCLOPHOSPHATES and 2',5'-OLIGOADENYLATES with antipapilloma virus activity |
| 05/06/1999 | CA2658884A1 Metal/thiol biocides |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308454A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2304815A1 .beta.-d glucan topical composition |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 05/05/1999 | CN1215595A External use medicine for treating soft tissue injury and its producing method |
| 05/05/1999 | CN1043227C Ceramide, preparation and application in comsetic and dermatological pharmaceutical of same |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | US5900231 Cosmetic and/or dermatological skin treatment |
| 05/04/1999 | CA2184604C Bicyclic carbamates |
| 05/04/1999 | CA2137001C Lipids for epidermal moisturization and repair of barrier function |
| 05/04/1999 | CA2108008C Antimicrobial compositions useful for medical applications |
| 04/29/1999 | WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | WO1999020614A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1999 | WO1999020608A1 Isoquinolines as urokinase inhibitors |
| 04/29/1999 | WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | WO1999020280A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | WO1999020232A1 Cosmetic formulations for the prevention and therapy of hair loss |
| 04/29/1999 | WO1999020121A2 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 04/29/1999 | CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | CA2306985A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911020A1 Methylstyrene derivatives as UV-filters and cosmetic and pharmaceutical preparations containing them |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910410A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 04/28/1999 | EP0910383A1 The use of growth factor modulating compounds |
| 04/28/1999 | EP0910367A2 Esters of vitamin e as products for topical application |
| 04/28/1999 | EP0910362A1 Oxa acids and related compounds for treating skin conditions |
| 04/28/1999 | EP0910354A1 Antioxidant compounds |
| 04/28/1999 | EP0779888B1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 04/28/1999 | EP0655907B1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215333A Use of derivativ |
| 04/28/1999 | CN1215330A Antiseptic skin care composition and method for making same |
| 04/28/1999 | CN1215328A Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 04/28/1999 | CN1215323A Skin care composition |
| 04/28/1999 | CN1215310A Method of killing or inhibiting microbial cells |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5897871 Therapeutic agent for the treatment of melanomas |
| 04/27/1999 | CA2163778C Indole derivatives as steroid 5a-reductase inhibitors |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/22/1999 | WO1999019505A1 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018928A1 Personal cleansing compositions comprising mid-chain branched surfactants |
| 04/22/1999 | WO1999018920A1 A new powerful cosmetic or pharmaceutical composition |
| 04/22/1999 | WO1999018919A2 Topical compositions for regulating the oily/shiny appearance of skin |
| 04/22/1999 | WO1999013717B1 A delivery of arginine to cause beneficial effects |
| 04/22/1999 | WO1999004806A9 Methods and compositions for inhibiting angiogenesis |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1999001118A3 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | CA2305507A1 A new powerful cosmetic or pharmaceutical composition |
| 04/21/1999 | EP0909763A2 Colchicine derivatives and the therapeutical use thereof |
| 04/21/1999 | EP0909557A1 Use of honey as an agent for decreasing micro-organisms adhesion |
| 04/21/1999 | EP0909173A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 04/21/1999 | CN1214675A Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 04/21/1999 | CN1214634A Antipruritic agent |
| 04/21/1999 | CN1214261A Oral medicine for curing dermatosis |
| 04/21/1999 | CN1214241A Cosmetic skin lightening product for topical application |
| 04/20/1999 | US5895755 Platelet derived growth factor |
| 04/20/1999 | US5895660 Deuterated active substances in transdermal application |
| 04/20/1999 | US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists |
| 04/20/1999 | CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 04/15/1999 | WO1999018219A1 A keratinocyte derived protease |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999017765A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999004821A3 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 04/15/1999 | WO1998055118A3 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 04/15/1999 | DE19811047C1 Copper-containing ribonucleoproteins |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2305805A1 Compounds and methods |
| 04/15/1999 | CA2305708A1 A keratinocyte derived protease |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |